SunHydrogen ab dem Jahre 2021

Quelle #525

The number of shares of registrant’s common stock outstanding, as of September 30, 2024 was 5,205,759,708.  

Quelle #525

We were formed in February 2009 and are currently developing a new technology that has not yet gained market acceptance. There can be no assurance that we will ever operate profitably or that we will have adequate working capital to meet our obligations as they become due.

"...that has not yet gained market acceptance."  

Quelle #525

As of June 30, 2024, we have an accumulated deficit of $91,852,243. For the year ended June 30, 2024, we incurred a net loss of $9,881,203. We expect to incur net losses until we are able to realize revenues to fund our continuing operations. We may fail to achieve any or significant revenues from sales or achieve or sustain profitability. Accordingly, we may never be profitable or be able to maintain profitability.

Defizit bei 91,8 Millionen Dollar.  

Quelle #525

As of June 30, 2024, we have outstanding shares of redeemable Series C Preferred Stock with an aggregate stated value of $885,100 that are convertible into common stock at a fixed conversion price of $0.00095 (see Note 3 to the financial statements included in this report). We anticipate that our issuance of common stock upon conversion of outstanding preferred shares will result in dilution to holders of our common stock, which may have a negative effect on the price of our common stock. In addition, as of June 30, 2024, we have outstanding warrants to purchase 78,095,239 shares of common stock and options to purchase 266,894,499 shares of common stock, and our issuance of shares of common stock upon exercise of outstanding warrants or options may result in additional dilution to our stockholders.

 

Quelle #525

As of June 30, 2024, we had a working capital surplus of $42,386,683, compared to a working capital surplus of $47,689,381 as of June 30, 2023. This decrease in working capital surplus of $5,302,698 was primarily due to a decrease in marketable securities redeemed, and the change in fair value of a short-term investment.

Cash flow used in operating activities was $1,842,726 for the year ended June 30 2024, compared to $4,262,085 for the year ended June 30, 2023. The decrease of $2,419,359 in cash used by operating activities was primarily due to an increase in non-cash expense offset by a decrease in net loss. The Company has had no revenues during the years ended June 30, 2024 and 2023.

Cash provided by investing activities for the year ended June 30, 2024 was $2,920,237, compared to $11,101,386 for the year ended June 30, 2023. The decrease of $8,181,149 in cash provided by investing activities was primarily due to a decrease in the net redemption of marketable securities offset by a decrease in the purchase of related party investments, the purchase of a related party convertible note, and an increase in the redemption of short-term investments in corporate securities.

Cash provided by financing activities during the year ended June 30, 2024 was $781,295, compared to $2,665,203 for the year ended June 30, 2023. The decrease in cash provided by financing activities was primarily due to a decrease in net proceeds from purchase agreements.

Das über die letzten 14 Jahre per Aktienverkauf eingenommene Cash reicht noch für ca. 6-8 Jahre. Für den Aufbau einer eigenen Produktion wird es in ca. 3-4 Jahren eng. Man kann sich später aber auch in Abhängigkeiten begeben und auf die $2,5/kg verzichten, mit denen man seit Jahren Werbung macht. Dann kann Tim Young aber trotzdem beruhigt in Rente gehen...Dank Disclaimer und Safe Harbour Statements. NmM.  

Quelle #525
       16.§SUBSEQUENT EVENTS
Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855 and had the following subsequent events to report.

On September 6, 2024, the Company issued 32,051,283 shares of common stock at a price of $0.0156 per share in the amount of $500,000, pursuant to a purchase notice under the purchase agreement.

On September 13, 2024, the Company issued 37,055,336 shares of common stock at a price of $0.02024 per share in the amount of $750,000, pursuant to a purchase notice under the purchase agreement.

On September 16, 2024, Mark Richardson resigned as a director of SunHydrogen, Inc. Mr. Richardson’s resignation will be effective September 30, 2024. Mr. Richardson’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

On September 30, 2024, the Company issued 49,407,115 shares of common stock at a price of $0.02024 per share in the amount of $1,000,000, pursuant to a purchase notice under the purchase agreement.  

war im letzten Jahr 2023 das vorletzte SEC-Filing des Jahres. Danach kam nur noch ein 10-Q. Ist SEC-seitig jetzt auch Funkstille bis 2025? https://www.sec.gov/cgi-bin/...1481028&owner=exclude&count=40

 

https://www.sec.gov/ix?doc=/Archives/edgar/data/...2-10k_sunhydro.htm

"The CEO of the Company elected to not seek reelection to the board of directors at the annual general meeting in June and is no longer a director of TECO after June 19, 2024. The CEO of the Company never received compensation of any kind for his role as director from January of 2023 through June 19, 2024."

Total 29,328,619 shares
Cost Basis  $ 10,139,302
Fair value as of
June 30,2024 $ 4,101,402  

https://www.sec.gov/ix?doc=/Archives/edgar/data/...28-8k_sunhydro.htm

Mr. Raney will be eligible to receive compensation for his service as a director that is approved by the Board from time to time and will receive an initial grant of stock options to purchase ten million shares of the Company’s common stock (the “Stock Options”). The Stock Options will be subject to the terms and conditions of the Company’s 2022 Equity Incentive Plan and a stock option agreement.

 

https://www.sunhydrogen.com/news-posts/...s-gen-1-demonstration-units

SunHydrogen Provides Update and Shares Newly Taken Images of its Gen 1 Demonstration Units

Drei Jahre später, in 2024, redet niemand mehr über GEN 1 und die 100 Demonstration Panels. Alter Tobak. Gen 2 auch Alter Tobak in 2027?
 

nicht noch mehr Geld der Aktionäre in TECO2030 versenkt. Andererseits liegt der größte Teil des Cashbestandes brach und wartet darauf, für Aufwendungen ausgegeben zu werden. NmM.  

weitere Experimente ala TECO wagt und falls ja mit welchem Ausgang.  

Nur werden diese "großen Firmenpartner" sicherlich keine Geschenke verteilen. Auch in Richtung Sunhydrogen nicht.  

Stimmrechte auf alle Forderungen der Partner - auch zum Nachteil der bisherigen Aktionäre - mit Änderungen in den Geschäfts- und Finanzierungsbedingungen reagieren, da es niemanden  gibt, der ihn überstimmen könnte.  

muss er sich dafür nicht einmal rechtfertigen. Klasse, was man an der US OTC alles tun kann, um Geld zu scheffeln. Und schlau, seine Aktien in Deutschland nur im Freiverkehr zu notieren und nicht im regulierten Marktsegment. NmM.  

Es ist nur eine Prognose. Das darf man nicht vergessen. Bei Sunhydrogen muss man eh nur zurückblicken, um zu erkennen, was Tim Young eingehalten hat und was nicht.  

0,oo7 Ziel